New Phase Appoints Renowned U.S. Cancer Expert Prof. Jeff Geschwind to Scientific Advisory Board for Oncology Treatment

Positive

AI Analysis

Summary

New Phase, a clinical-stage medical device company, appointed Prof. Jeff Geschwind, a renowned interventional oncology and radiology expert, to its Scientific Advisory Board to support FDA discussions and feasibility study preparations for an oncology treatment.

Importance:3/10

Sentiment:

0.30

Medical DeviceOncologyScientific Advisory BoardInterventional OncologyFDA Discussions

Related Companies

$DFPH $MDCE

Read the original article

Published by PR Newswire Biotech on July 22, 2026 6:10 PM

Read Original